NCT05819671

Brief Summary

to investigate prevalence of upper limb musculoskeletal disorders and correlations to glycemic control.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 19, 2023

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

April 19, 2023

Status Verified

December 1, 2022

Enrollment Period

6 months

First QC Date

April 6, 2023

Last Update Submit

April 6, 2023

Conditions

Upper Limb Musculoskeletal Abnormalities

Outcome Measures

Primary Outcomes (1)

  • prevalence of upper limb musculoskeletal disorders and correlations to glycemic control

    3 months

Study Arms (2)

Groupe(A)

Group (A)diabetics - g

group(B)

group B normal is a normal control(non-diabetics)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

diabetics type 2 - comparable control

You may qualify if:

  • patients will be included to this study(cases) if they are: 1) Diabetic patients. 2) Age \> 18 years. 3) Diagnosed as type 2.

You may not qualify if:

  • \- Patients will be excluded if they have rheumatoid arthritis, other rheumatological diseases or previous upper limb surgeries.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al ahrar teaching hospital

Zagazig, Sharqia Province, 44511, Egypt

RECRUITING

Study Officials

  • Eslam Dr Shohda, hd,pt

    GOTHI

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eslam Elsayed Shohda, PHD,PT

CONTACT

01009482231dreslamelsayed@hotmail.com

Hadder Khaled Abd elhameed, DPT

CONTACT

01112663032dreslamelsayed@hotmail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
General Committee of Teaching Hospitals and Institutes, Egypt

Study Record Dates

First Submitted

April 6, 2023

First Posted

April 19, 2023

Study Start

November 1, 2022

Primary Completion

May 1, 2023

Study Completion

May 1, 2023

Last Updated

April 19, 2023

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

data only for study researchers and the organization under which the study is conducted

Locations

EG(1)